Phibro Animal Health Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Phibro Animal Health stock has a consensus rating of "Hold" and an average price target of $45.6. The average 1-year stock price forecast is 46.51% higher than the current stock price, while the lowest is $38 (+22.09%) and the highest is $58 (+86.35%).

Price Target: $45.6 (+46.51%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$38	$45.6	$44	$58
Change	+22.09%	+46.51%	+41.37%	+86.35%

Analyst Ratings

The average analyst rating for Phibro Animal Health stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Oct '25	Nov '25	Feb '26	Apr '26	May '26	Jun '26
Strong Buy	0	0	0	0	0	0
Buy	1	1	1	1	1	1
Hold	2	2	2	3	3	3
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	4	4	4	5	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ekaterina Knyazkova J.P. Morgan	J.P. Morgan	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Jun 12, 2026
Michael Ryskin Bank of America Securities	Bank of America Securities	Sell Maintains $27 → $38	Sell	Maintains	$27 → $38	+22.09%	Jun 5, 2026
Daniel Grosslight Citi	Citi	Hold Reiterates $62 → $44	Hold	Reiterates	$62 → $44	+41.37%	May 13, 2026
Erin Wright Morgan Stanley	Morgan Stanley	Hold Maintains $45 → $49	Hold	Maintains	$45 → $49	+57.43%	Feb 6, 2026

Financial Forecast

Revenue This Year

1.50B

from 1.30B

15.55%

from 1.30B

Revenue Next Year

1.55B

from 1.50B

3.32%

from 1.50B

EPS This Year

3.07

from 2.09

46.99%

from 2.09

EPS Next Year

3.34

from 3.07

8.85%

from 3.07

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Jun 30, 2021	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026
Revenue	833.35M	942.26M	977.89M	1.02B	1.30B	1.50B
Revenue Growth	4.12%	13.07%	3.78%	4.07%	27.37%	15.55%
Gross Profit	271.38M	285.72M	298.24M	313.61M	405.62M	513.75M
Gross Margin	32.56%	30.32%	30.50%	30.82%	31.29%	34.30%
Operating Income	74.87M	78.38M	71.85M	63.54M	133.56M	212.69M
Net Income	54.39M	49.18M	32.61M	2.42M	48.26M	101.01M
EPS	-	-	-	-	2.09	3.07
EPS Growth	-	-	-	-	75.63%	46.99%
Forward PE	21.57	14.49	10.22	14.49	10.58	10.13
Dividend / Share	0.48	0.48	0.48	0.48	0.48	0.48
Dividend Growth	-	-	-	-	-	-0.48%
Free Cash Flow	14.20M	429.38K	-33.57M	57.79M	-86.50M	84.35M
No. Analysts	-	-	-	-	-	5

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	1.5B
Avg	1.5B
Low	1.5B

Revenue Growth

Revenue Growth	2026	2027	2028
High	16.6%
Avg	15.6%
Low	14.1%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	3.07
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	47.0%
Low	-